Abstract: A temperature control system includes a compressor, a condenser, an evaporator, a receiver, and an accumulator. A valve is positioned between the evaporator and the receiver. An evacuation line has a first end in fluid communication with heat transfer fluid between the valve and the receiver, and a second end in fluid communication with the accumulator. The evacuation line provides for flow of the heat transfer fluid from both of the first heat exchanger and the receiver to the accumulator during an evacuation mode of operation of the temperature control system. The valve can take the form of a check valve or an expansion valve without a bleed port.

Abstract: A memory circuit includes a plurality of bit line structures (each including a true and a complementary bit line), a plurality of word line structures intersecting the plurality of bit line structures to form a plurality of cell locations; and a plurality of cells located at the plurality of cell locations. Each of the cells includes a logical storage element, a first access transistor selectively coupling a given one of the true bit lines to the logical storage element, and a second access transistor selectively coupling a corresponding given one of the complementary bit lines to the logical storage element. One or both of the first and second access transistors are configured with asymmetric current characteristics to enable independent enhancement of READ and WRITE margins. Also included within the 6-T scope are one or more design structures embodied in a machine readable medium, comprising circuits as set forth herein.

Abstract: The present invention relates to compositions for use in refrigeration, air-conditioning, and heat pump systems wherein the composition comprises a fluoroolefin and at least one other component. The compositions of the present invention are useful in processes for producing cooling or heat, as heat transfer fluids, foam blowing agents, aerosol propellants, and fire suppression and fire extinguishing agents.

Abstract: The present invention provides methods of use of oxadiazoanthracene derivatives of the formula (I) and pharmaceutically acceptable salts thereof, wherein A, B, C, R, R1, R2, R3, R4 and R5 are as herein described, and wherein said methods of use include uses for the treatment and/or prevention of disorders and diseases, such as diabetes.

Abstract: A mobile device comprising a camera and color detection software stored in memory of the mobile device, wherein the color detection application analyzes and displays component colors in a captured image and compares component colors in two such captured images. The color detection application displays component colors in a specific format such as red, green and blue and displays percentage of these colors in each of the compared images. The color detection provides textual and audio feedbacks of the extent of match between colors of the two images. The two captured images that are to be compared are displayed in split windows. A client-application compares a first digital image with a second digital image and describes the closeness of a color of the first digital image to the color of the second digital image.

Abstract: A braze alloy composition for sealing a ceramic component to a metal component in an electrochemical cell is presented. The braze alloy composition includes nickel, germanium, and an active metal element. The braze alloy includes germanium in an amount greater than about 5 weight percent, and the active metal element in an amount less than about 10 weight percent. A method for sealing a ceramic component to a metal component in an electrochemical cell and, an electrochemical cell sealed thereby, are also provided.

Abstract: The present invention relates to solid, semisolid, or liquid formulations comprising water soluble antioxidants that prevent or reduce formic acid and/or formyl species generation in the dosage form during the manufacturing process and/or during shelf-life storage. The formulations of the present invention prevent or reduce formation of N-formyl impurities (and gelatin cross-linking) during the manufacturing process and/or during shelf-life storage.

Abstract: Most semiconductor devices manufactured today, have uniform dopant concentration, either in the lateral or vertical device active (and isolation) regions. By grading the dopant concentration, the performance in various semiconductor devices can be significantly improved. Performance improvements can be obtained in application specific areas like increase in frequency of operation for digital logic, various power MOSFET and IGBT ICS, improvement in refresh time for DRAM's, decrease in programming time for nonvolatile memory, better visual quality including pixel resolution and color sensitivity for imaging ICs, better sensitivity for varactors in tunable filters, higher drive capabilities for JFET's, and a host of other applications.

Abstract: The invention provides orally administered antitussive pharmaceutical compositions comprising dextromethorphan, wherein the compositions are free of bromide, sodium and polistirex.

Abstract: A controlling node for a cellular communications system, arranged to determine and transmit commands for Transmit Power Control, TPC, to one or more Mobile Terminals, MTs, in at least one cell in the system. The controlling node is arranged to classify an MT as being in one of a number of states, and to use differing methods for determining an MT's TPC command depending on which state the MT is in, so that one method is used for determining TPC commands to an MT in the active state and another method is used for determining TPC commands to an MT in the passive state.

Abstract: The present invention relates to compounds of Formula (I) along with processes for their preparation that are useful for treating, preventing and/or managing the diseases, disorders, syndromes or conditions associated with the modulation of CRAC. The invention further relates to methods of treating, preventing managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of CRAC of Formula (I).

Abstract: A semiconductor device includes a substrate comprising a semiconductor material. The substrate has a surface that defines a surface normal direction and includes a P-N junction comprising an interface between a first region and a second region, where the first (second) region includes a first (second) dopant type, so as to have a first (second) conductivity type. The substrate includes a termination extension region disposed adjacent to the P-N junction and having an effective concentration of the second dopant type that is generally the effective concentration of the second dopant type in the second doped region. The substrate includes an adjust region disposed adjacent to the surface and between the surface and at least part of the termination extension region, where the effective concentration of the second dopant type generally decreases when moving from the termination extension region into the adjust region along the surface normal direction.

Abstract: A non-contact RFID reader reads a code contained on an RFID tag carried by a driver of a vehicle. The code is assigned to a specific individual expected to operate the vehicle. An electronic module in the vehicle contains a data file uniquely associated with the code, and the data file contains physical characteristics of the driver that may be pertinent to proper functioning of safety systems of the vehicle, such as weight, height, age, and sex. Performance parameters of restraints and/or other safety systems, such as an airbag associated with the driver's seating position are adapted in accordance with the physical characteristics in the data file. The RFID reader may read multiple tags on board the vehicle, so that restraints for multiple seating positions in addition to the driver's seat may be adapted to the individual occupying those positions.

Abstract: Embodiments of the present disclosure provide methods, apparatuses, and systems including a memory device including content addressable memory configured to store an address associated with one or more memory cells while an access operation is performed on the one or more memory cells. Other embodiments may be described.

Abstract: A system for, and method of, generating block timing constraints and a timing model. In one embodiment, the system includes a hierarchical modeling tool configured to: (1) generate a model file, (2) receive at least one abstracted view margin, at least one timing environment margin and at least one operational margin for inclusion in the model file, (3) generate block implementation timing constraints employing the at least one timing environment margin and the at least one operational margin and (4) generate a block timing model employing the at least one abstracted view margin and the at least one operational margin.

Abstract: Mechanisms are provided for accelerated data deduplication. A data stream is received an input interface and maintained in memory. Chunk boundaries are detected and chunk fingerprints are calculated using a deduplication accelerator while a processor maintains a state machine. A deduplication dictionary is accessed using a chunk fingerprint to determine if the associated data chunk has previously been written to persistent memory. If the data chunk has previously been written, reference counts may be updated but the data chunk need not be stored again. Otherwise, datastore suitcases, filemaps, and the deduplication dictionary may be updated to reflect storage of the data chunk. Direct memory access (DMA) addresses are provided to directly transfer a chunk to an output interface as needed.

Abstract: The present invention relates to compound of formula I, which are functionalized, non-phenolic amino acids, and polymers formed from the same. Polymers formed from the functionalized amino acids are expected to have controllable degradation profiles, enabling them to release an active component over a desired time range. The polymers are also expected to be useful in a variety of medical applications.

Abstract: The present invention provides a compound of general formula 7, useful as potential antitumour agents against five human cancer cell lines. The present invention further provides a process for the preparation of pyrrolo[2,1-c][1,4]benzodiazepine linked imidazo[1,5-a]pyridine conjugates attached through a piperazine moiety and different alkane spacers of general formula 7 wherein R represents H, OCH3, CF3, CN, F or Cl; n=3, 4, 5 or 6.

Abstract: Task placement is influenced within a multiple processor computer. Tasks are classified as either memory bound or CPU bound by observing certain performance counters over the task execution. During a first pass of task load balance, tasks are balanced across various CPUs to achieve a fairness goal, where tasks are allocated CPU resources in accordance to their established fairness priority value. During a second pass of task load balance, tasks are rebalanced across CPUs to reduce CPU resource contention, such that the rebalance of tasks in the second pass does not violate fairness goals established in the first pass. In one embodiment, the second pass could involve re-balancing memory bound tasks across different cache domains, where CPUs in a cache domain share a same last mile CPU cache such as an L3 cache.

Abstract: An access-terminal routing methodology is provided that may be used to enable a wireless, meshed backhaul between base stations using existing wireless-access resources (time, bandwidth, code-space, power), protocols, and base station infrastructure. Accordingly, the invention provides a means to extend the coverage of existing networks by adding standalone base stations without wired or specialized wireless backhaul.